Preview

Медицинский алфавит

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Доступ платный или только для Подписчиков

Неврологические синдромы целиакии

https://doi.org/10.33667/2078-5631-2020-33-39-48

Полный текст:

Аннотация

Целиакия – это аутоиммунное заболевание у людей с генетической предрасположенностью, возникающее вследствие потребления белков глютена пшеницы, ржи, ячменя и характеризующееся воспалением слизистой тонкой кишки и атрофией ворсинок. Полиневропатия, мигрень, хроническая мозжечковая атаксия и фибромиалгия – это самые частые экстраинтестинальные синдромы целиакии. Исследование тонких нервных волокон необходимо при таких болезненных синдромах целиакии, как глютеновая полиневропатия и фибромиалгия, а также при глютеновой вегетативной полиневропатии. Исследование антинейрональных антиганглиозидных антител необходимо при таких поражениях центральной и периферической нервной системы, как глютеновая полиневропатия и глютеновая мозжечковая атаксия. Аглютеновая диета напрямую влияет на исчезновение приступов головной боли или на уменьшение их частоты и интенсивности. Имеется мало исследований по влиянию аглютеновой диеты на риск развития головной боли.

Об авторах

С. В. Копишинская
ФГБОУ ВО «Кировский государственный медицинский университет» Минздрава России; АО «Ферст Генетикс», Инновационный центр Сколково
Россия

к. м. н., доцент

г. Киров

Москва



С. С. Никитин
Региональная общественная организация «Общество специалистов по нервномышечным болезням», Медицинский центр «Практическая неврология»
Россия

д. м. н., проф.

Москва



Список литературы

1. Lebwohl B, Rubio-Tapia A. Epidemiology, Presentation, and Diagnosis of Celiac Disease. Gastroenterology. 2020 Sep 17: S 0016–5085 (20) 35165–9. DOI: 10.1053/j.gastro.2020.06.098.

2. Lebwohl B., Sanders D. S. Coeliac disease. Green Lancet. 2018; 391: 70–81. http://dx.doi.org/10.1016/S01406736(17)31796–8

3. Hugh J. Freeman. Celiac disease: a disorder from antiquity, its evolving classification and risk, and potential new treatment. Gut Liver. 2015; 9: 28–37. http://dx.doi.org/10.5009/gnl14288

4. Murray J. A., Frey M. R., Oliva-Hemker M. Celiac Disease. Gastroenterology. 2018. http://dx.doi.org/10.1053/j.gastro.2017.12.026

5. Парфенов А. И., Маев И. В., Баранов А. А., Бакулин И. Г., Сабельникова Е. А., Крумс Л. М., Бельмер С. В., Боровик Т. Э., Захарова И. Н., Дмитриева Ю. А., Рославцева Е. А., Корниенко Е. А., Хавкин А. И., Потапов А. С., Ревнова М. О., Мухина Ю. Г., Щербаков П. Л., Федоров Е. Д., Белоусова Е. А., Халиф И. Л., Хомерики С. Г., Ротин Д. Л., Воробьева Н. Г., Пивник А. В., Гудкова Р. Б., Быкова С. В., Чернин В. В., Вохмянина Н. В., Пухликова Т. В., Дегтярев Д. А., Дамулин И. В., Мкртумян А. М., Джулай Г. С., Тетруашвили Н. К., Барановский А. Ю., Назаренко Л. И., Харитонов А. Г., Лоранская И. Д., Яковенко Э. П., Сайфутдинов Р. Г., Ливзан М. А., Абрамов Д. А., Осипенко М. Ф., Орешко Л. С., Ткаченко Е. И., Ситкин С. И., Ефремов Л. И. Всероссийский консенсус по диагностике и лечению целиакии у детей и взрослых. Клинические рекомендации. http://dx.doi.org/10.17116/terarkh201789394–107.

6. Gasbarrini G. B., Mangiola F. Wheat-related disorders: A broad spectrum of ‘evolving’ diseases. United European Gastroenterol. J. 2014; 2 (4): 254–262. http://dx.doi.org/10.1177/2050640614535929

7. Lionetti E., Gatti S., Pulvirenti A., Catassi C. Celiac disease from a global perspective. Best Practice & Research Clinical Gastroenterology. 2015; 29: 365–379. http://dx.doi.org/10.1016/j.bpg.2015.05.004

8. Rodríguez-Martín L, Vaquero L, Vivas S. New celiac disease biomarkers. Rev. Esp. Enferm. Dig. 2020 Oct; 112(10): 792–796. DOI: 10.17235/reed.2020.7217/2020. Верхневолжский медицинский журнал. 2013, № 11 (2). С. 42–48.

9. Castillo N. E., Theethira T. G., Leffler D. A. The present and the future in the diagnosis and management of celiac disease. Gastroenterology Report. 2015; 3 (1): 3–11. http://dx.doi.org/10.1093/gastro/gou065

10. Dieli-Crimi R., Carm C. M. The genetics of celiac disease: A comprehensive review of clinical implications. Journal of Autoimmunity. 2015: 1–16. http://dx.doi.org/10.1016/j.jaut.2015.07.003

11. Losurdo G., Principi M., Iannone A., Amoruso A., Ierardi E., Leo A. D., Barone M. Extra-intestinal manifestations of non-celiac gluten sensitivity: an expanding paradigm. World J. Gastroenterol. 2018; 24 (14): 1521–1530. http://dx.doi.org/10.3748/wjg.v24.i14.1521

12. Malamut G., Cellier C. Complications of coeliac disease. Best Practice & Research Clinical Gastroenterology. 2015; 29: 451–458. http://dx.doi.org/10.1016/j.bpg.2015.05.005

13. Hadjivassiliou M., Duker A. P., Sanders D. S. Gluten-related neurologic dysfunction. Handb. Clin. Neurol. 2014; 120: 607–619. http://dx.doi.org/10.1016/B978–0–7020–4087–0.00041–3

14. Leffler D. A., Green P. H., Fasano A. Extraintestinal manifestations of coeliac disease. Nat. Rev. Gastroenterol. Hepatol. 2015; 12 (10): 561–571. http://dx.doi.org/10.1038/nrgastro.2015.131

15. Ehsani-Ardakani M.J., RostamiNejad M., Villanacci V., Volta U., Manenti S., Caio G., Giovenali P., Becheanu G., Diculescu M., Pellegrino S., Magazzù G., Casella G., Di Bella C., Decarli N., Biancalani M., Bassotti G., Hogg-Kollars S., Zali M. R., Rostami K. Gastrointestinal and non-gastrointestinal presentation in patients with celiac disease. Arch. Iran. Med. 2013; 16 (2): 78–82. http://dx.doi.org/013162/AIM.006

16. Luostarinen L., Pirttila T., Collin P. Coeliac disease presenting with neurological disorders. Eur. Neurol. 1999; 42 (3): 132–135. http://dx.doi.org/10.1159/000008086

17. Nunes G., Barosa R., Patita M., Fernandes V., Gonçalves D., Fonseca J. World J. Adult Celiac Disease: The Importance of Extraintestinal Manifestations. Gastroenterol. 2017; 24: 292–295. http://dx.doi.org/10.1159/000461593

18. Aksoy E., Tıraş-Teber S., Kansu A., Deda G., KartalA. Neurological findings spectrum in Celiac disease. The Turkish Journal of Pediatrics. 2016; 58: 233–240. DOI: 10.24953/turkjped.2016.03.001.

19. Anderson B., Pitsinger A. Improvement in Chronic Muscle Fasciculations With Dietary Change: A Suspected Case of Gluten Neuropathy. Journal of Chiropractic Medicine. 2014; 13: 188–191. http://dx.doi.org/10.1016/j.jcm.2014.01.002

20. Callaghan B. C., Price R. S., Feldman E. L. Distal symmetric polyneuropathy: a review. JAMA. 2015; 314: 2172–2181. http://dx.doi.org/10.1001/jama.2015.13611

21. Reda H., Chin–Semin R. L. Peripheral neuropathies of rheumatologic disease and gluten-related disorders. Neurol.2014; 34: 413–424. http://dx.doi.org/10.1055/S-0034–1390390

22. Tarabzouni S., AlKhairallah T. Isolated neurological manifestation in silent celiac disease. J. Mov. Disord. 2017; 10 (2): 105–107. http://dx.doi.org/10.14802/jmd.16063

23. Barbato M., Curione M., Amato S., et al. Autonomic imbalance in celiac children. Minerva. Pediatr. 2010; 62 (4): 333–338.

24. Kaplan J. G., Pack D., Horoupian D., DeSouza T., Brin M., Schaumburg H. Distal axonopathy associated with chronic gluten enteropathy: a treatable disorder. Neurology. 1988; 38 (4): 642–645. DOI: 10.1212/wnl.38.4.642.

25. Brannagan T. H. 3rd, Hays A. P., Chin S. S., Sander H. W., Chin R. L., Magda P., et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch. Neurol. 2005; 62: 1574–1578. http://dx.doi.org/10.1001/archneur.62.10.1574

26. Gibbons C. H., Freeman R. Autonomic neuropathy and coeliac disease. J. Neurol. Neurosurg. Psychiatry. 2005; 76 (4): 579–581. http://dx.doi.org/10.1136/jnnp.2004.047480

27. Lang M., Treister R., Oaklander A. L. Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy. J. Neurol. 2016; 263 (12): 2515–2527. https://doi.org/10.1007/s00415–016–8270–5

28. Farhad K., Traub R., Ruzhansky K. M., Brannagan T. H. 3rd. Causes of neuropathy in patients referred as «idiopathic neuropathy».Muscle Nerve. 2016; 53 (6): 856–861. http://dx.doi.org/10.1002/mus.24969

29. Burk K., Farecki M. L., Lamprecht G., et al. Neurological symptoms in patients with biopsy proven celiac disease. Mov Disord 2009; 24 (16): 2358–2362. DOI: 10.1002/mds.22821.

30. Oaklander A. L. Immunotherapy prospects for painful small-fiber sensory neuropathies and ganglionopathies. Neurotherapeutics. 2016; 13 (1): 108–117. http://dx.doi.org/10.1007/s13311–015–0395–1

31. Oaklander A. L., Herzog Z. D., Downs H. M., Klein M. M. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain. 2013; 154 (11): 2310–2316. http://dx.doi.org/10.1016/j.pain.2013.06.001

32. Oaklander A. L. What is the meaning of ‘small-fiber polyneuropathy’ in fibromyalgia? An alternate answer. Pain. 2016; 157 (6): 1366–1367. http://dx.doi.org/10.1097/j.pain.0000000000000526

33. Tursi A, Giorgetti GM, Iani C, Arciprete F, Brandimarte G, Capria A, et al. Peripheral neurological disturbances, autonomic dysfunction, and antineuronal antibodies in adult celiac disease before and after a gluten-free diet. Dig. Dis. Sci. 2006; 51: 1869–1874. DOI: 10.1007/s10620–005–9054–4.

34. Elfstrom P., Sundstrom J., Ludvigsson J. F. Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment. Pharmacol. Ther. 2014; 40: 1123–1132. http://dx.doi.org/10.1111/apt.12973

35. Thawani S., Brannagan T. H., Lebwohl B., Mollazadegan K., Green P. H., Ludvigsson J. F. Type 1 diabetes, celiac disease, and neuropathy – a nationwide cohort study. J. Clin. Neuromusc. Dis. 2017; 19: 12–18. DOI: 10.1097/CND.0000000000000174.

36. Dennis M., Lee A. R., McCarthy T. Nutritional Considerations of the Gluten-Free Diet. Gastroenterol. Clin. North. Am. 2019 Mar; 48 (1): 53–72. DOI: 10.1016/j.gtc.2018.09.002.

37. Anandacoomaraswamy D., Ullal J., Vinik A. L. A 70-yearold male with peripheral neuropathy, ataxia and antigliadin antibodies shows improvement in neuropathy, but not ataxia, after intravenous immunoglobulin and gluten-free diet. J. Multidiscip. Healthc. 2008; 1: 93–96. DOI: 10.2147/jmdh.s3018.

38. Luostarinen L., Himanen S. L., Luostarinen M., Collin P., Pirttil T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J. Neurol. Neurosurg. Psychiatry. 2003; 74 (4): 490–494. DOI: 10.1136/jnnp.74.4.490.

39. Caio G., De Giorgio R., Venturi A., Giancola F., Latorre R., Boschetti E. Clinical and immunological relevance of anti-neuronal antibodies in celiac disease with neurological manifestations. Gastroenterol. Hepatol. Bed. Bench. 2015; 8 (2): 146–152.

40. Estévez V., Ayala J., Vespa C., Araya M. The gluten-free basic food basket: a problem of availability, cost and nutritional composition. Eur. J. Clin. Nut. 2016; 70 (10): 1215–1217. http://dx.doi.org/10.1038/ejcn.2016.139

41. Hadjivassiliou M., Kandler R. H., Chattopadhyay A. K., et al. Dietary treatment of gluten neuropathy. Muscle.Nerve. 2006; 34 (6): 762–766. http://dx.doi.org/10.1002/mus.20642

42. Briani C., Riggero S., Zara G., et al. Anti-ganglioside antibodies in children with celiac disease: correlation with gluten-free diet and neurological complications. Aliment Pharmacol.Ther.2004; 20: 231–235. DOI: 10.1196/annals.1361.056.

43. Volta U., Caio G., Giancola F., Rhoden K. J., Ruggeri E., Boschetti E., Stanghellini V., De Giorgio R. Features and progression of potential celiac disease in adults. Clin. Gastroenterol. Hepatol. 2016; 14 (5): 686–693. http://dx.doi.org/10.1016/j.cgh.2015.10.024

44. Freeman H. J. Dietary compliance in celiac disease. World J. Gastroenterol. 2017; 23 (15): 2635–2639. http://dx.doi.org/10.3748/wjg.v23.i15.2635

45. Kaur Bilkhoo H., Ducruet T., Marchand V., Deslandres C., Djemli A., Dal Soglio D., Patey N. Revisiting pathological criteria for earlier diagnosis of coeliac disease. J. Pediatr. Gastroenterol.Nutr. 2016; 62 (5): 734.738. http://dx.doi.org/10.1097/MPG.0000000000001026

46. Garnier-Lenglin H., Cerf-Bensussan N., Ruemmele F. M. Celiac disease in children. Clin. Res. Hepatol. Gastroenterol.2015; 39: 544–551. http://dx.doi.org/10.3390/ijerph14070785

47. Sel Ç. G., Aksoy E., Aksoy A., Yüksel D., Özbay F. Neurological manifestations of atypical celiac disease in childhood. Acta. Neurol. Belg. 2017; 117 (3): 719–727. http://dx.doi.org/10.1007/s13760–017–0781-z

48. Shapiro M., Blanco D. A. The neurological manifestations of gastrointestinal disease. Seminars in Pediatric Neurology. 2017; 24 (1): 43–53. http://dx.doi.org/10.1016/j.spen.2017.02.001

49. Boskovic A., Stankovic I. Axonal and demyelinating polyneuropathy associated with celiac disease. Indian pediatrics. 2014; 51 (4): 311–312. DOI: 10.1007/s13312–014–0385–0.

50. Santos M. O., Ohana, B., de Carvalho M. Celiac disease and a novel association with a multifocal acquired motor axonopathy (MAMA). Clinical Neurophysiology. 2017; 128 (9): 1596–1598. DOI: http://dx.doi.org/10.1016/j.clinph.2017.06.038

51. Gupta V., Kohli A. Celiac disease associated with recurrent Guillain Barre Syndrome. Indian Pediatr. 2010; 47: 797–798. DOI: 10.1007/s13312–010–0105–3.

52. Pacitto A., Paglino A., Di Genova L., Leonardi A., Farinelli E., Principi N., di Cara G., Esposito S. Celiac disease presenting with peripheral neuropathy in children: a case report. J. Environ. Res. Public Health 2017; 14: 785. http://dx.doi.org/10.3390/ijerph14070785

53. Kelly C. P., Bai J. C., Liu E., Leffler D. A. Advances in diagnosis and management of celiac disease. Gastroenterology. 2015; 148 (6): 1175–1186. http://dx.doi.org/10.1053/j.gastro.2015.01.044

54. Keon A., Lennon V. A., Pittock S. J., Kryzer T. J., Murray J. The neurologic significance of celiac disease biomarkers. Neurology 2014; 83 (20): 1789–1795. http://dx.doi.org/10.1212/WNL.0000000000000970

55. Klöck С., DiRaimondo T.R., Khosla С. Role of Transglutaminase 2 in Celiac Disease Pathogenesis. Semin. Immunopathol. 2012. N. 34. Р. 513–522. DOI: 10.1007/s00281–012–0305–0.

56. Meresse B., Malamut G., Cerf-Bensussan N. Celiac Disease: an immunological jigsaw. Immunity.2012; 29: 907–9119. https://doi.org/10.1016/j.immuni.2012.06.006

57. Szondy Z., Korponay-Szabó I., Király R., Sarang Z., Tsay G. J. Transglutaminase 2 in human diseases. Bio Medicine. 2017; 7 (3): 1–13. http://dx.doi.org/10.1051/bmdcn/2017070315

58. Balint B., Vincent A., Meinck H. M., Irani S. R., Bhatia K. P. Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain. 2018; 141 (1): 13–36. http://dx.doi.org/10.1093/brain/awx189

59. Lytton S, Antiga E, Pfeiffer S, Matthias T, Poplawska AS, Ulaganathan K, et al. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the glutensensitive skin disease – Dermatitis herpetiformis. Clin. Chim. Acta. 2013; 415: 346–9. DOI: 10.1016/j.cca.2012.10.051.

60. Lerner A, Makhoul B, Eliakim R. Neurological manifestations of celiac disease in children, adults. Eur Neurol J. 2010; 000: 1–6. DOI: 10.1542/peds.113.6.1672.

61. Kochhar G. S., Singh T., Gill A., Kirby D. F. Celiac disease: managing a multisystem disorder. Cleve Clin. J. Med. 2016; 83 (3): 217–227. http://dx.doi.org/10.3949/ccjm.83a.14158

62. McKeon A, Lennon VA, Pittock SJ, Kryzer TJ, Murray J. The neurologic significance of celiac disease biomarkers.Neurology. 2014; 83 (20): 1789–1796. DOI: 10.1212/WNL.0000000000000970.

63. Avila D., Lacomis D. Proximal limb weakness in a patient with celiac disease: copper deficiency, gluten sensitivity, or both as the underlying cause? Neurological Medicine.2016; Article ID 5415949, 4 pages. http://dx.doi.org/10.1155/2016/5415949

64. Patterson SK, Green PH, Tennyson CA, Lewis SK, Brannagan TH III. Copper levels in patients with celiac neuropathy. J. Clin. Neuromuscul. Dis. 2012; 14 (1): 11–16. DOI: 10.1097/CND.0b013e318260b455.

65. Chin R. L., Sander H. W., Brannagan T. H., Green P. H., Hays A. P., Alaedini A, et al. Celiac neuropathy. Neurology.2003; 60: 1581–1585. DOI: 10.1212/01.wnl.0000063307.84039.c7.

66. Sander H. W., Magda P., Chin R. L., et al. Cerebellar ataxia and coeliac disease. Lancet. 2003; 362 (9395): 1548. DOI: 10.1016/S0140–6736(03)14743–5.

67. Rashtak S., Snyder M. R., Pittock. J., Wu T.-T., Gandhi M. J., Murray J. A. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidatedgliadin antibody. J. Neuroimmunol. 2011; 230 (1–2): 130–134. http://dx.doi.org/10.1016/j.jneuroim.2010.09.024

68. Przybylska-Felus M., Furgala A., Zwolinska-Wcislo M., Mazur M., Widera A., Thor P., Mach T. Disturbances of autonomic nervous system activity and diminished response to stress in patients with celiac disease. J. Physiol. Pharmacol.2014; 65 (6): 833–41.

69. Usai P., Usai Satta P., Savarino V., Boy M. F. Autonomic neuropathy in adult celiac disease. Am. J. Gastroenterol. 1996; 91 (8): 1676–1677.

70. Anil S. Bhavsar, Verma S., Lamba R., Chandana G. Lall, Koenigsknecht V., Rajesh A. Abdominal manifestations of neurologic disorders. Radio Graphics. 2013; 33: 135–153. https://doi.org/10.1148/rg.331125097

71. Pinto-Sánchez M.I., Bercik P., Verdu E. F., Bai J. C. Extraintestinal Manifestations of Celiac Disease. Dig. Dis. 2015; 33: 147–154. http://dx.doi.org/10.1159/000369541

72. Rydzewska G. Markers of autonomic nervous system impairment in celiac disease: we know the questions to ask but we still do not have answers. Pol. Arch. Med. Wewn. 2016; 126 (11): 842–844. http://dx.doi.org/10.20452/pamw.3697

73. Valenti S., Corica D., Ricciardi L., Romano C. Gluten-related disorders: certainties, questions and doubts. Annals of Medicine. 2017. http://dx.doi.org/10.1080/07853890.2017.1325968

74. Bai J. C., Fried M., Corazza G. R., Schuppan D., Farthing M., Catassi C., Greco L., Cohen H., Ciacci C., Eliakim R., Fasano A., Gonza´lez A., Krabshuis J. H., LeMair A. World gastroenterology organisation global guidelines on celiac disease. J. Clin. Gastroenterol. 2013; 47 (2): 121–126. http://dx.doi.org/10.1097/MCG.0b013e31827a6f83.

75. Mennini M., Baglivo I., Ferrari F. Neuropathy and celiac disease–when a gluten-free diet is not enough. Neurology. 2015; 72 (10): 1208–1209. http://dx.doi.org/10.1001/jamaneurol.2015.2069

76. Maiya RP, Messing RO. Peripheral systems: neuropathy. Handb Clin Neurol. 2014; 125: 513–525. DOI: 10.1016/B9780–444–62619–6.00029-X.

77. Shen T. C., Lebwohl B., Verma H., et al. Peripheral neuropathic symptoms in celiac disease and inflammatory bowel disease. J. Clin. Neuromuscul. Dis. 2012; 13 (3): 137–145. DOI: 10.1097/CND.0b013e31821c55a1.

78. Ludvigsson J. F., Olsson T., Ekbom A., Montgomery S. M. A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases. Aliment. Pharmacol. Ther. 2007; 25 (11): 1317–1327. https://doi.org/10.1111/j.1365–2036.2007.03329.x

79. Thawani S., Brannagan T. H., Lebwohl B., Green P. H., Ludvigsson J. F. Risk of neuropathy among 28232 patients with biopsy-verified celiac disease. Pediatric Neurology Briefs. 2015; 29 (7): 55. http://dx.doi.org/10.15844/pedneurbriefs-29–7–6

80. Chin R. L., Tseng V. G., Green P. H., Sander H. W., Brannagan T. H. III, Latov N. Multifocal axonal polyneuropathy in celiac disease. Neurology. 2006; 66 (12): 1923–1925. http://dx.doi.org/10.1212/01.wnl.0000208413.40583.6c

81. Cicarelli G., Della Rocca G., Amboni M., et al. Clinical and neurological abnormalities in adult celiac disease. Neurol. Sci. 2003; 24 (5): 311–317. http://dx.doi.org/10.1007/s10072–003–0181–4

82. Green P. H., Krishnareddy S., Lebwohl B. Clinical manifestations of celiac disease. Dig. Dis. 2015; 33 (2): 137–140. http://dx.doi.org/10.1159/000370204

83. Stowe R. C., Karkare S., Puri V. Case report of subacute cerebellar ataxia of adolescence with long-term sequelae. J. Child Neurol. 2012. № 28 (12). P. 1653–1660. DOI: 10.1177/0883073812460583.

84. Kowalczyk M. U., Śmigielski J., Gmitrowicz A. Neuropsychiatric symptoms and celiac disease.Neuropsychiatric Disease and Treatment. 2014; 10: 1961–1964. http://dx.doi.org/10.2147/NDT.S6909

85. Campagna G., Pesce M., Tatangelo R., Rizzuto A., La FrattaI., GrilliA.The progression of coeliac disease: its neurological and psychiatric implications. Nutrition Research Reviews. 2017; 30 (1): 25–35. http://dx.doi.org/10.1017/S0954422416000214

86. Casella G., Bordo B. M., Schalling R., Villanacci V., Salemme M., Di Bella C., Baldini V., BassottiG. Neurological disorders and celiac disease. Minerva. Gastroenterol. Dietol. 2016; 62 (2): 197–206.

87. Kang J. Y., Kang A. H., Green A, Gwee K. A. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013. № 38. Р. 26–45. DOI: 10.1111/apt.12373.

88. Hadjivassiliou M., Wallis L. I., Hoggard N., Grünewald R. A. MR spectroscopy and atrophy in Gluten, Friedreich's and SCA6 ataxias. Acta Neurol. Scand. 2011. № 126 (2). P. 138–143. DOI: 10.1016/j.neurad.2012.08.003.

89. Lock R. J., Tengah P., Unsworth D. J., Ward J. J. Ataxia, peripheral neuropathy, and anti-gliadin antibody. Guit by association? J. Neurol. Neurosurg. Psychiatry. 2005. № 76. P. 1601–1603. DOI: 10.1136/jnnp.2004.058487.

90. Jarius S., Wildemann B. ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR 1, anti-Homer-3, anti-Sj/ITPR 1 and anti-CARP VIII. Journal of Neuroinflammation. 2015; 12: 166. https://doi.org/10.1186/s12974–015–0356-y

91. Zis P, Sarrigianni P. G., Rao D. G., Hoggard N., Sanders D. S., HadjivassiliouM. Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play. Cerebellum & Ataxias. 2017; 4: 20. http://doi.org/10.1186/s40673–017–0079–1

92. Combarros Q., Infante J., Lopez-Hoyos M., Bartolome M. J. Celiac disease and idiopatic cerebellar ataxia. American Academy of Neurology. 2000. № 13. P. 2346–2352. DOI: 10.1212/wnl.54.12.2346.

93. Hernandez L., Green P. H. Extraintestinal manifestations of celiac disease. Curr. Gastroenterol. Rep. 2006; 8 (5): 383–389. DOI: 10.1007/s11894–006–0023–7.

94. Nanri K., Makoto S., Takeshi T., Akira H. Selective loss of Purkinje cells in a patient with anti-gliadin-antibody-positive autoimmune cerebellar ataxia. Diagn. Pathol. 2011. № 6. P. 14–19. DOI: 10.1186/1746–1596–6–14.

95. Habek M., Hojsak I., Barun B., Brinar V. V. Downbeat nystagmus, ataxia and spastic tetraparesis due to coeliac disease. Neurol. Sci. 2011; 32 (5); 911–914. DOI: 10.1007/s10072–011–0506–7.

96. Hadjivassiliou M., Sanders D. D., Aeschlimann D. P. Gluten-Related Disorders: Gluten Ataxia. Dig Dis. 2015; 33: 264–268. http://doi.org/10.1159/000369509

97. Hadjivassiliou M., Aeschlimann P., Sanders D. S., et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013: 80 (19): 1740–1745. http://dx.doi.org/10.1212/WNL.0b013e3182919070

98. Hadjivassiliou M., Aeschlimann P., Strigun A., Sanders D. S., Woodroofe N., Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann. Neurol. 2008; 64 (3): 332–343. http://dx.doi.org/10.1002/ana.21450

99. Lindfors K., Koskinen O., Laurila K. et al. IgA-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: no evidence for gluten dependency. Acta Clin. Chim. 2011. № 412 (13–14). Р. 1187–1190. DOI: 10.1016/j.cca.2010.09.042.

100. Wilkinson I. D., Hadjivassiliou M., Dickson J. M., Wallis L. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J. Neurol. Neurosurg. Psychiatry. 2005. № 76 (7). Р. 1011–1013. DOI: 10.1136/jnnp.2004.049809.

101. Kumar J., Kumar M., Pandey R., Chauhan N. S. Physiopathology and Management of Gluten-Induced Celiac Disease. Journal of Food Science. 2017; 82 (2): 270–277. http://dx.doi.org/10.1111/1750–3841.13612

102. Hadjivassiliou M., Rao D. G., Grünewald R. A., Aeschlimann D. P., Sarrigiannis P. G., Hoggard N., Aeschlimann P., Mooney P. D., Sanders D. S. Neurological dysfunction in coeliac disease and non-coeliac gluten sensitivity. Am. J. Gastroenterol. 2016; 111: 561–567. http://dx.doi.org/10.1038/ajg.2015.434

103. Lau M. S., Sanders D. S. Optimizing the diagnosis of celiac disease. Curr. Opin. Gastroenterol. 2017; 33 (3): 173–180. http://dx.doi.org/10.1097/MOG.0000000000000343.

104. Pennisi M., Bramanti A., Cantone M., Pennisi G., Bella R., Lanza G. Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections. Front Neurosci. 2017; 11: 498. http://dx.doi.org/10.3389/fnins.2017.0049

105. Currie S., Hadjivassiliou M., Clark M. J. et al. Alcohol Induces Sensitization to Gluten in Genetically Susceptible Individuals: A Case Control Study. J. Neurol. Neurosurg. Psychiatry. 2012. № 83 (12). P. 1216–1221. DOI: 10.1371/journal.pone.0077638.

106. Versino M., Franciotta D., Colnaghi S. et al. Cerebellar signs in celiac disease. Neurology. 2009. № 2 (23). P. 2046–2048. DOI: 10.1212/WNL.0b013e3181a92c12.

107. Крумс Л. М., Парфенов А. И., Сабельникова Е. А., Гудкова Р. Б., Воробьева Н. Н. Лечение и профилактика глютенчувствительной целиакии. Экспериментальная и клиническая гастроэнтерология. 2011. № 2. С. 86–92.

108. Kaukinen K., Lindfors K., Mäki M. Advances in the treatment of coeliac disease: an immunopathogenic perspective. Nat. Rev. Gastroenterol. Hepatol. 2013. № 6. Р. 38–41. DOI: 10.1038/nrgastro.2013.141.

109. Kurada S., Yadav A., Leffler D. A. Current and novel therapeutic strategies in celiac disease. Expert Rev. Clin. Pharmacol. 2016; 9 (9): 1211–1223. http://dx.doi.org/10.1080/17512433.2016.12004633

110. Mukherjee R., Kelly C. P., Schuppan D. Nondietary therapies for celiac disease.GastrointestEndosc. Clin. N. Am. 2012. № 22. Р. 11–31. DOI: 10.1016/j.giec.2012.09.001.

111. Lahoz C. H., Saez L. R., Villar J. V., Capdevila G. M., Juanes J. M. Familial Gluten Ataxia. Movement Disorders. 2014; 29: 3. http://dx.doi.org/10.1002/mds.25783

112. Le Gal J., Michel J. F., Rinaldi V. E., Spiri D., Moretti R. Association between functional gastrointestinal disorders and migraine in children and adolescents: a case-control study. The Lancet Gastroenterology & Hepatology. 2016; 1 (2): 114–21. https://doi.org/10.1016/S2468–1253(16)30038–3

113. Petrarca L., Nenna R. Headache and celiac disease: an increasingly investigated association. American Headache Society. 2016; 56 (9): 1520–1521. http://dx.doi.org/10.1111/head.12958

114. Zelnik N, Pacht A, Obeid R, Lerner A. Range of neurologic disorders in patients with celiac disease. Pediatrics (2004) 113: 1672–6. DOI: 10.1542/peds.113.6.1672

115. Dimitrova A. K., Ungaro R. C., Lebwohl B., Lewis S. K., Tennyson C. A., Green M. W. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache. 2013; 53: 344–55. http://dx.doi.org/10.1111/j.1526–4610.2012.02260.x

116. Alehan F., Ozcay F., Erol I., Canan O., Cemil T. Increased risk for coeliac disease in paediatric patients with migraine. Cephalalgia. 2008; 28: 945–949. http://dx.doi.org/10.1111/j.1468–2982.2008.01630.x

117. Lebwohl B., Roy A., Alaedini A., Green P. H.R. Risk of headache-related healthcare visits in patients with celiac disease: a population-based observational study. DOI: 10.1111/head.127842016.

118. Cámara-Lemarroy C.R., Rodriguez-Gutierrez R., Monreal-Robles R., Marfil-Rivera A. Gastrointestinal disorders associated with migraine: a comprehensive review. World J. Gastroenterol. 2016; 22 (36): 8149–8160. http://dx.doi.org/10.3748/wjg.v22.i36.8149

119. Mormile R. Celiac disease and migraine: is there a common backstage? J. Colorectal. Dis. 2014; 29: 1571. http://dx.doi.org/10.1007/s00384–014–1923-x

120. Pfeiffer R. F. Gastroenterology and Neurology. Continuum. Continuum (Minneap. Minn.). 2017 Jun; 23 (3, Neurology of Systemic Disease): 744–761. DOI: 10.1212/CON.0000000000000484.

121. Ciaccio E. J., Bhagat G., Lewis S. K., Green P. H. Quantitative image analysis of celiac disease.World J. Gastroenterol. 2015; 21 (9): 2577–2581. http://dx.doi.org/10.3748/wjg.v21.i9.2577

122. Addolorato G, Di Giuda D, De Rossi G, Valenza V, Domenicali M, Caputo F, Gasbarrini A, Capristo E, Gasbarrini G. Regional cerebral hypoperfusion in patients with celiac disease. Am J Med. 2004 Mar 1; 116 (5): 312–7. DOI: 10.1016/j.amjmed.2003.09.037.

123. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia. 2007. Vol. 27, N 11. P. 1293–1300. DOI: 10.1111/j.1468–2982.2007.01476.x.

124. Tavakkoli A., Green P. H. Probiotic therapy for сeliac disease. J. Clin. Gastroenterol. 2013; 47 (2): 101–103. http://dx.doi.org/10.1097/MCG.0b013e31827b507d

125. Hindiyeh N., Aurora S. K. What the gut can teach us about migraine Curr. Pain. Headache. Rep. 2015; 19 (7): 33. https://doi.org/10.1007/s11916–015–0501–4 PMID:26049770

126. Rahmoune H., Boutrid N. Migraine, celiac disease and intestinal microbiota. Pediatr Neurol Briefs. 2017 Feb; 31 (2): 6. DOI: 10.15844/pedneurbriefs-31–2–3.

127. Chen X., D’Souza R., Hong S. T. The role of gut microbiota in the gut brain axis: current challenges and perspectives. Protein Cell. 2013; 4: 403–414. http://dx.doi.org/10.1007/s13238–013–3017-x

128. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun (2014) 38. C: 1–12. DOI: 10.1016/j.bbi.2013.12.01.

129. Waszczuk E., Waszczuk K. Gluten, Dysbiosis, and Genetics in Celiac Disease: All Are Important. Dig. Dis. Sci. 2016; 61: 2761–2762. http://dx.doi.org/10.1007/s10620–016–4264–5

130. Verdu E. F., Galipeau H. J., Jabri B. Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 2015; 12 (9): 497–506. http://dx.doi.org/10.1038/nrgastro.2015.90

131. Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, et al. An update on the use and investigation of probiotics in health and disease. Gut (2013) 62: 787–96. DOI: 10.1136/gutjnl-2012–302504.

132. Collins S. M., Surette M., Bercik P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 2012; 10: 735–742. http://dx.doi.org/10.1038/nrmicro2876

133. Sensenig J, Johnson M, Staverosky T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev (2001) 6: 488–94.

134. Mulder C. J., Wierdsma N. J., Berkenpas M., Jacobs J. M., Bouma G. Preventing complications in celiac disease: our experience with managing adult celiac disease. Best Pract. Res. Clin. 2015; 29: 459–468. http://dx.doi.org/10.1016/j.bpg.2015.05.006

135. Табеева Т. Г. Фибромиалгия: формирование симптомов и принципы терапии. Неврология, нейропсихиатрия и психосоматика. 2012, № 1. P. 23–27.

136. Bennett R., Friend R., Marcus D., et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary ACR criteria and the development of alternative criteria. Arthritis Care. Res. (Hoboken) 2014; epub ahead of print. http://dx.doi.org/10.1002/acr.22301

137. Cristofori F., Fontana C., Magistà A., Capriati T., Indrio F., Castellaneta S. et al. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome: a 6-year prospective cohort study. JAMA Pediatr. 2014; 168 (6): 555–60. https://doi.org/10.1001/jamapediatrics.2013.4984

138. Smith H. S., Harris R., Clauw D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011, № 14. P. 217–245.

139. Sarzi-Puttini P., Atzeni F., Di Franco M., Buskilla D., Alciati A., Giacomelli C., Rossi A., Bazzichi L. Dysfunctional syndromes and fibromyalgia: a 2012 critical digest. Clin. Exp. Rheumatol. 2012. № 30. P. 143–151.

140. Rani U., Imdad A., Beg M. Rare neurological manifestation of celiac disease. Case Rep. Gastroenterol. 2015; 9: 200–205. http://dx.doi.org/10.1159/000431170

141. García-Leiva J.M., Carrasco J. L., Slim M., Calandre E. P. Celiac symptoms in patients with fibromyalgia: a crosssectional study. Rheumatol Int. 2015; 35 (3): 561–567. http://dx.doi.org/10.1007/s00296–014–3110–3

142. Yunus M. B. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res. Treat. 2012, № 12. P. 584–573. DOI: 10.1155/2012/584573.

143. Sainsbury A., Sanders D. S., Ford A. C. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin. Gastroenterol. Hepatol. 2013, № 11. P. 359–365. DOI: 10.1016/j.cgh.2012.11.033.

144. Isasi C., Colmenero I., Casco F., Tejerina E., Fernandez N., SerranoVela J.I., Castro M. J., Villa L. F. Fibromyalgia and nonceliac gluten sensitivity: a description with remission of fibromyalgia. Rheumatol Int. 2014; 34: 1607–1612. http://dx.doi.org/10.1007/s00296–014–2990–6

145. Slim M., Calandre E. P., Villademoros F. R. An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatol Int. 2015; 35: 433–444. http://dx.doi.org/10.1007/s00296–014–3109–9

146. Zwolinska-Wcislo M., Galicka-Latala D., Rozpondek P., Rudnicka-Sosin L. et al. Frequency of celiac disease and irritable bowel syndrome coexistence and its influence on the disease course. Przegl. Lek. 2009, № 66. P. 126–129.

147. Rodrigo L., Blanco I., Bobes J., de Serres F. J. Remarkable prevalence of celiac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res. Therapy. 2013. № 15. P. 1–12. DOI: 10.1186/ar4391.

148. Tovoli F., Masi C., Guidetti E., Negrini G., Paterini P., Bolondi L. Clinical and diagnostic aspects of gluten related disorders. World J. Clin. Cases. 2015; 3 (3): 275–284. http://dx.doi.org/10.12998/wjcc.v3.i3.275

149. Tovoli F., Giampaolo L., Caio G., Monti M. et al. Fibromyalgia and coeliac disease: a media hype or an emerging clinical problem? Clin. Exp. Rheumatol. 2013. № 31. P. 50–52.

150. Giannoccaro M. P., Donadio V., Incensi A., Avoni P., Liguori R. Small nerve fiber involvement in patients referred for fibromyalgia. Muscle. Nerve. 2014; 49 (5): 757–759. http://dx.doi.org/10.1002/mus.24156

151. Lodahl M, Treister R, Oaklander AL. Specific symptoms may discriminate between fibromyalgia patients with vs without objective test evidence of small-fiber polyneuropathy. Pain Rep. 2017; 3 (1): 633. DOI: 10.1097/PR9.0000000000000633.

152. Nisihara R., Marques A. P., Mei A., Skare T. Celiac disease and fibromyalgia: Is there an association? Rev. Esp. Enferm. Dig. 2016; 108 (2) 6. 107–108. http://dx.doi.org/10.17235/reed.2015.3992/2015

153. Oqeyler N, Sommer C. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 2013; 154 (11): 2569. DOI: 10.1016/j.pain.2013.06.037.

154. Oqeyler N., Zeller D., Kahn A. K., et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain. 2013; 136(6): 1857–1867. http://dx.doi.org/10.1093/brain/awt053

155. Gill D., Derry S., Wiffen P. J., Moore R. A. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane. Database. Syst. Rev. 2011; (10): 83–91. DOI: 10.1002/14651858.CD009183.pub2.

156. Hearn L, Derry S, Moore RA. Lacosamide for neuropathic pain and fibromyalgia in adults. Cochrane. Database. Syst. Rev. 2012; 15(2): CD 009318. http://dx.doi.org/10.1002/14651858.CD009318.pub2

157. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011; (3): CD 007938. DOI: 10.1002/14651858.CD007938.pub4.

158. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012; 12: CD 008242. DOI: 10.1002/14651858.CD008242.pub3.

159. Wright A., Luedtke K. E., Vandenberg C. Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy. J. Pain. Res. 2011; 4: 1–10. http://dx.doi.org/10.2147/JPR.S12866


Для цитирования:


Копишинская С.В., Никитин С.С. Неврологические синдромы целиакии. Медицинский алфавит. 2020;(33):39-48. https://doi.org/10.33667/2078-5631-2020-33-39-48

For citation:


Kopishinskaia S.V., Nikitin S.S. Neurological syndromes of celiac disease. Medical alphabet. 2020;(33):39-48. (In Russ.) https://doi.org/10.33667/2078-5631-2020-33-39-48

Просмотров: 59


ISSN 2078-5631 (Print)